soha el masry

Dr. soha el masry

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
EMEman Mazyed
Eman Mazyed
Farid BadriaFarid Badria
Farid Badria
MEMai H ElNaggar
Mai H ElNaggar
SMsoha el masry
soha el masry
SHSally Helmy
Sally Helmy
The poor solubility and stability of 6-gingerol (6-G) could hamper its clinical applications. The aim of the current study was to develop a novel ultra-deformable cyclodextrin-functionalized transethoniosomes (CD-TENs) as a promising delivery system for 6-G. Transethoniosomes (TENs) are flexible niosomes (NVs) due to their content of ethanol and edge activators (EAs). CD-functionalized nanoparticles could improve drug solubility and stability compared to the corresponding nanovesicles. 6-G-loaded ethoniosomes (ENs) were formulated by the ethanol injection technique in the presence and absence of EA and CD to explore the impact of the studied independent variables on entrapment efficiency (EE%) and % 6-G released after 24 h (Q24h). According to the desirability criteria, F8 (CD-functionalized transethoniosomal formula) was selected as the optimized formulation. F8 demonstrated higher EE%, permeation, deformability and stability than the corresponding TENs, ENs and NVs. Additionally, F8 showed higher cytotoxic and anti-inflammatory activity than pure 6-G. The synergism between complexation with CD and novel ultra-deformable nanovesicles (TENs) in the form of CD-TENs can be a promising drug delivery carrier for 6-G.

21 May 2024 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
MBMarwa Belal
Marwa Belal
GLGihan Salah Labib
Gihan Salah Labib
Doaa A GhareebDoaa A Ghareeb
Doaa A Ghareeb
MHMaged Wasfy Helmy
Maged Wasfy Helmy
SMsoha el masry
soha el masry

15 May 2024 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
SMsoha el masry
soha el masry
EMEman Mazyed
Eman Mazyed
RERasha M. El-Morsi
Rasha M. El-Morsi
SKShaimaa M. Khedr
Shaimaa M. Khedr
AAAbeer E. Abdelwahab
Abeer E. Abdelwahab
SHSally A. Helmy
Sally A. Helmy

8 September 2022 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
SHSally A. Helmy
Sally A. Helmy
RERasha M. El-Morsi
Rasha M. El-Morsi
SHSoha A.M. Helmy
Soha A.M. Helmy
SMsoha el masry
soha el masry


26 July 2020 in Therapeutic Delivery
Verified
Journal Article
Closed access
SHSally Helmy
Sally Helmy
HEHeba M El-Bedaiwy
Heba M El-Bedaiwy
SMsoha el masry
soha el masry
Aim: To study the impact of various permeability enhancers on fexofenadine bioavailability. Furthermore, to predict the potential effect of Cremophor® RH 40 on fexofenadine pharmacokinetics at high...